All articles
Prostate Cancer
Effects of ligand activation of PPAR-gamma in human prostate cancer – (10-26-00)
James Bogash
Effects of ligand activation of PPAR-gamma in human prostate cancer
I’ve said many times before that I truly believe that most chronic diseases in humans stems from relatively few biochemical defects. This is yet more evidence of this. The new class of diabetic drugs have been shown to inhibit prostate cancer. Just remember that conjugated linoleic acid (CLA) is also a PPAR-gamma ligand without the known hepatotoxicity.
PNAS — Abstracts: Mueller et al. 97 (20): 10990
